Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time.

author

  • Kelsey, Karl Director of Center for Environmental Health and Technology, Professor of Epidemiology, Professor of Pathology and Laboratory Medicine